Bioniche Pharma Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 120


  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

  • Investments
  • 6

Bioniche Pharma General Information


Bioniche Pharma was a manufacturer of generic injectable pharmaceuticals. The company was involved in the development, manufacturing and marketing of sterile injectable products and other pharmaceuticals for human health. It used to offer injectable pharmaceutical products serving a variety of niche markets, with expertise in injectable hyaluronic acid products for use in orthopedics, rheumatology, urology, and dermatology. On September 9, 2010 the firm was acquired by Mylan.

Contact Information

Ownership Status
Financing Status
Formerly PE-Backed
Primary Industry
Corporate Office
  • Unit 6 - Casla Industrial Estate
  • Costelloe
  • County Galway
  • Ireland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioniche Pharma Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bioniche Pharma‘s full profile, request access.

Request a free trial

Bioniche Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioniche Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bioniche Pharma‘s full profile, request access.

Request a free trial

Bioniche Pharma Investments (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
GeneraMedix (Seven Products) 12-Feb-2010 0000000000 Pharmaceuticals 00000 000
Xanodyne Pharmaceuticals (Duraclon and Methadone Hydrochloride Injection USP Product Line) 12-Nov-2009 0000000000 Buildings and Property 00000 000
Baxter Healthcare (Enlon product line) 02-Jul-2008 0000000000 Buildings and Property 00000 000
Metrics Pharmaceutical Ventures (Esmolol Hydrochloride) 25-May-2007 0000000000 Pharmaceuticals 00000 000
Nabi Biopharmaceuticals (Aloprim) 19-Apr-2007 Buyout/LBO 00.00 Pharmaceuticals 00000 000
You’re viewing 5 of 6 investments. Get the full list »

Bioniche Pharma FAQs

  • When was Bioniche Pharma founded?

    Bioniche Pharma was founded in 1992.

  • Where is Bioniche Pharma headquartered?

    Bioniche Pharma is headquartered in Costelloe, Ireland.

  • What is the size of Bioniche Pharma?

    Bioniche Pharma has 120 total employees.

  • What industry is Bioniche Pharma in?

    Bioniche Pharma’s primary industry is Pharmaceuticals.

  • Is Bioniche Pharma a private or public company?

    Bioniche Pharma is a Private company.

  • What is the current valuation of Bioniche Pharma?

    The current valuation of Bioniche Pharma is 00000.

  • What is Bioniche Pharma’s current revenue?

    The current revenue for Bioniche Pharma is 000000.

  • How much funding has Bioniche Pharma raised over time?

    Bioniche Pharma has raised $4.55M.

  • Who are Bioniche Pharma’s investors?

    Bank of Scotland, ICC Venture Capital, RoundTable Healthcare Partners, and Telesta Therapeutics have invested in Bioniche Pharma.

  • When was Bioniche Pharma acquired?

    Bioniche Pharma was acquired on 07-Sep-2010.

  • Who acquired Bioniche Pharma?

    Bioniche Pharma was acquired by Mylan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »